Chugai Pharmaceutical Co. Ltd.

Chugai Pharmaceutical Co. Ltd. Stock

23.49P/E
€67.62BMarket capitalisation
JP¥306.09Earnings
1.82 %Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra (hemophilia), Actemra (rheumatoid arthritis, covid), Foundayo (oral obesity pill), and Nemluvio (atopic dermatitis, prurigo nodularis).

Chugai Pharmaceutical Co. Ltd. is registered in the following country: Japan (Exchange: JPTSE).

Key metrics

Key metrics and master data for the Chugai Pharmaceutical Co. Ltd. stock.

Market capitalisation
€67.62B
P/E
23.49
P/B
5.69
P/S
8.37
P/CF
27.30
Issued shares 2B Units

Return

Here you can see the performance of the Chugai Pharmaceutical Co. Ltd. stock.

PeriodPerfor­mance
1 Week+1.73 %
1 Month+16.36 %
3 Months+13.01 %
6 Months-3.36 %
1 Year-12.14 %
YTD-7.02 %

Dividends

The Chugai Pharmaceutical Co. Ltd. stock pays an annual dividend. With an (expected) annual dividend of £0.7198, the current stock price results in a dividend yield of 1.82 %.

Dividend typeAnnual dividend
(Expected) annual dividend £0.7198
Dividend yield 1.82 %

Splits

The table shows the splits of the Chugai Pharmaceutical Co. Ltd. share.

DateRatio
29.06.20203:1

Which ETF contains the Chugai Pharmaceutical Co. Ltd. stock?

The Chugai Pharmaceutical Co. Ltd. stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Chugai Pharmaceutical Co. Ltd. has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Chugai Pharmaceutical Co. Ltd. stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.